Citi says Gilead’s (GILD) HIV franchise remains its biggest value driver. The firm believes a strong launch of lenacapavir in pre-exposure prophylaxis and expansion of several “differentiated ...

The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year. Why: The stock's decline ...

FOSTER CITY, Calif., March 12, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its ...

Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is under review by the Trump administration, and the Health and Human ...

Also Read: Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention At CROI 2025, the primary results of a Phase 2 study evaluating lenacapavir (LEN) with teropavimab (TAB) and ...

God saved Trump, prayer meetings before press conferences, and a certainty that THE LORD is on their side are just a few of ...

Gilead said it plans to start phase 3 trials later this year. SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice ...

The medicine, lenacapavir, made by Gilead Sciences, has caused a stir because clinical trial data showed a single set of injections every six months could provide virtually complete protection ...

For Gilead Christian, Joseph Bossard won the discus at 111-10. Marion Harding was fourth at the eight-team Red Raider Relays in London. Finishing third for the Presidents were the shuttle hurdles ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Winning events were the 4x800, 4x200 and 4x300 relays, and the 4x100 was a runner-up. Gilead Christian’s distance medley relay was second. Coaches and statisticians are encouraged to send their ...

FOSTER CITY, Calif., March 12, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative ...